SUCAMPO PHARMACEUTICALS
Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a late-stage pipeline of product candidates in clinical development for orphan disease areas. VTS-270 is a mixture of 2-hydroxypropyl-B-cyclodextrins with a specific compositional fingerprint that has been granted orphan designation in the U.S. and... Europe and is in a pivotal Phase 2/3 clinical trial for the treatment of Niemann-Pick Disease Type C-1. Sucampo has an option for the North American rights to CPP1- x/sulindac, which is in Phase 3 development for the treatment of familial adenomatous polyposis and has been granted orphan drug designation in the U.S. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan and Switzerland.
SUCAMPO PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1996-01-01
Address:
Bethesda, Maryland, United States
Country:
United States
Website Url:
http://www.sucampo.com
Total Employee:
51+
Status:
Active
Contact:
3019613440
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS IIS 10 Microsoft CPanel Shutterstock
Similar Organizations
Curtiss Healthcare
Curtiss Healthcare is a biopharmaceutical company.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-04-03 | Vtesse | Vtesse acquired by Sucampo Pharmaceuticals | N/A |
| 2015-10-31 | R-Tech Ueno | R-Tech Ueno acquired by Sucampo Pharmaceuticals | N/A |
Official Site Inspections
http://www.sucampo.com
- Host name: sucampo.com
- IP address: 146.214.96.210
- Location: St Louis United States
- Latitude: 38.6249
- Longitude: -90.4496
- Metro Code: 609
- Timezone: America/Chicago
- Postal: 63131
